Woman researching GLP-1 under $200 per month options on laptop in kitchen — know the real total before you choose

GLP-1 Under $200 Per Month: Which Options Are Real in 2026

By the Weight Loss Provider Guide team · Last verified April 15, 2026 · How we verified this · Affiliate disclosure

Short answer

Yes — getting a GLP-1 under $200 per month is possible in April 2026. But the honest list is way shorter than the ads suggest. The cleanest under-$200 paths right now are FDA-approved oral GLP-1 pills: Eli Lilly’s Foundayo at $149/month and Novo Nordisk’s Wegovy pill at $149/month at lower doses. On the compounded side, Eden and SHED start at or near $199/month. Everything else you’ve seen — MEDVi at “$179,” Eden at “$129” — is a first-month promo that jumps to $249–$299 on refill.

The real question isn’t what costs under $200 in month one. It’s what still costs under $200 in month six, at the dose your provider actually prescribes. That’s the math we did below — and the catch on each option is different.

What We Actually Verified (April 15, 2026)

Before building the comparison below, we checked each provider’s live pricing page and documented:

Advertised first-month price
Ongoing refill price (the number most pages hide)
Whether price increases as your dose increases
Membership or visit fees layered on top of medication cost
Cancellation window and auto-renewal terms
State availability where clearly stated
Any recent FDA enforcement action
Public review count and rating (Trustpilot)

Where a provider’s pricing page and checkout flow disagreed, or where we could not confirm a claim from a primary source, we marked it [NEEDS VERIFICATION] instead of guessing. Every dollar figure in the tables below is sourced from the provider’s own public pricing page unless otherwise noted.

GLP-1 under $200: What actually changes the answer — comparison of FDA-approved pill vs injection vs compounded oral vs compounded injection — Before you click: understand the four categories and what questions to ask for each.

The Under-$200 Reality Matrix

Which GLP-1 Programs Are Actually Under $200 Per Month?

Quick answer: Under-$200 GLP-1 access in April 2026 breaks into three tiers: FDA-approved oral pills at $149/month on lower doses (Foundayo via LillyDirect, Wegovy pill via NovoCare), compounded telehealth programs advertising $199/month at starter doses (Eden, SHED, SkinnyRx, TrimRx), and first-month-only promos that break the threshold on refill (MEDVi at $179 → $299, Ro Wegovy pen at $199 → $349).

Verified under $200

Tier 1 — Under $200 at lower doses (no long prepay required)

Route	Med type	Month 1	Ongoing starter	What breaks the price
LillyDirect Foundayo	FDA-approved oral (orforglipron)	$149 (0.8 mg)	$199 at 2.5 mg	Rises to $299/mo at 5.5 mg+ under labeled titration
NovoCare Wegovy pill	FDA-approved oral semaglutide	$149 (1.5 mg or 4 mg)	$149 at 4 mg through Aug 31, 2026 (then $199)	Jumps to $299/mo at 9 mg and 25 mg
Eden	Compounded semaglutide	As low as $129 [NEEDS VERIFICATION]	Varies by plan length [NEEDS VERIFICATION]	Eden states “same price at every dose” on compounded — confirm plan rate at checkout
SkinnyRx	Compounded semaglutide	As low as $199/mo*	$199/mo* advertised [NEEDS VERIFICATION]	*Asterisk on site — confirm plan terms at checkout
TrimRx	Compounded semaglutide	$199/mo advertised	Conflicting signals on commitment vs. monthly rate [NEEDS VERIFICATION]	Pricing may depend on plan length
SHED	Compounded semaglutide (inject or lozenge)	$199/mo (starting dose)	$249/mo at maintenance	Dose escalation; 2-month minimum; cancel 72 hrs before billing

Ready to compare?

Eden’s same-price-at-every-dose policy is the standout in the compounded tier.

Requires prepay

Tier 2 — Under $200 only with prepay commitment

Provider	Medication	Prepay required	Effective per month
TrimRx (annual)	Compounded semaglutide	12 months	$99/mo per landing page [NEEDS VERIFICATION]
TrimRx (6-month)	Compounded semaglutide	6 months	$124/mo per landing page [NEEDS VERIFICATION]

Month 1 only

Tier 3 — Under $200 first month only (the “bait zone”)

Provider	Advertised month 1	Actual month 2+	Jump
MEDVi compounded semaglutide	$179	$299	+67%
Ro Wegovy pen (intro, through June 30, 2026)	$199 (first 2 fills only)	$349	+75%
Walgreens + Wegovy pill ($49 visit + $149 med)	~$198	$299+ at higher doses	+51%+

What about Ro and GoodRx?

Both are popular but land above $200 once you add their required membership fee:

Ro Body: Medication starts at $149/month (Wegovy pill or Foundayo) — but Ro Body membership adds $39 the first month, then as low as $74/month on annual prepay or $149/month monthly. Cheapest ongoing all-in: roughly $223/month even with annual discount. Ro is available in all 50 states and D.C.
GoodRx: Displays a $39/month subscription plus medication starting at $149/month on current live pages. A November 2025 press release indicated the standard subscription would become $119 starting February 1, 2026 — putting total cost at $188–$268/month. [NEEDS VERIFICATION — confirm live checkout price before relying on this]

Neither is a bad option — Ro in particular offers strong clinical support and an insurance concierge. But they are not clean under-$200 answers once fees are counted honestly.

Important notes on the entire matrix

Compounded GLP-1 medications are prepared by licensed U.S. compounding pharmacies under a clinician’s prescription. They are not FDA-approved as finished products and have not been evaluated by the FDA for safety, effectiveness, or quality.
Dose-based pricing means the price often rises as your prescribed dose rises. Your clinician — not the telehealth platform — determines your dose.
State availability varies by provider. Eden and Ro serve all 50 states; confirm availability for other providers during intake.
We re-verify all pricing monthly and update this page accordingly.

If you already know what you want:

Foundayo on LillyDirect Not sure? Take the quiz

Which Under-$200 GLP-1 Actually Fits Your Situation?

Quick answer: The right under-$200 path depends on four factors: whether you require FDA-approved medication or are open to compounded, whether you prefer pills or are comfortable with injections, how high your prescribed dose will go, and how long you’re willing to commit upfront. For FDA-approved seekers, Foundayo and the Wegovy pill start at $149/month. For compounded cash-pay buyers, Eden and SHED start at $199/month with varying plan structures.

If you want FDA-approved and you’re not comfortable with compounded

Start with Foundayo (LillyDirect) or the Wegovy pill (NovoCare / Ro)

Foundayo is Eli Lilly’s new daily oral GLP-1, FDA-approved on April 1, 2026 for weight management in adults with obesity or overweight with at least one weight-related health condition. The active ingredient is orforglipron — a small-molecule drug (not a peptide), which means it’s absorbed without the special stomach-acid workarounds other oral GLP-1s need. You take it once daily, any time of day, with or without food.

Foundayo dose-price ladder (LillyDirect self-pay):

0.8 mg → $149/mo2.5 mg → $199/mo5.5 mg+ → $299/mo

Under FDA-labeled titration: start at 0.8 mg, increase to 2.5 mg after 30 days, then 5.5 mg after another 30 days. The under-$200 window lasts roughly two months under standard dosing.

In late-stage clinical trials, participants taking the highest dose lost an average of 12.4% of body weight (~27.3 lbs) over 72 weeks vs 0.9% on placebo.

The Wegovy pill (oral semaglutide, FDA-approved December 2025 for chronic weight management) is $149/month through NovoCare at the 1.5 mg and 4 mg doses. The $149 price for the 4 mg dose is available through August 31, 2026, per NovoCare’s terms — after which it becomes $199/month. Higher doses (9 mg and 25 mg) are $299/month. In trials, the 25 mg Wegovy tablet produced approximately 13.6% average body weight reduction at Week 64 versus 2.4% on placebo.

Wegovy pill dose-price ladder (NovoCare self-pay):

1.5 mg → $149/mo4 mg → $149/mo (through Aug 31, 2026)9 mg / 25 mg → $299/mo

Who this fits:

Anyone who wants regulatory certainty of FDA-approved drugs
Anyone who prefers a daily pill over weekly injections
Anyone whose insurance might eventually cover brand-name GLP-1
Anyone on Medicare (Medicare GLP-1 Bridge begins July 1, 2026, $50 copay)

Who should look elsewhere:

People who will likely need higher maintenance doses (cost jumps to $299 at 9+ mg Wegovy pill or 5.5+ mg Foundayo)
People who want injectable GLP-1 (these are pills only)

Check Foundayo on LillyDirect

If compounded is acceptable and you want a flat or near-flat monthly price

Look at Eden or SHED first. Then verify SkinnyRx and TrimRx at checkout.

Eden — same price at every dose

Eden is a telehealth platform serving all 50 states that offers both compounded and FDA-approved GLP-1 medications under one platform. Their key differentiator is a “same price at every dose” policy on compounded semaglutide — your cost doesn’t jump as your provider titrates you up. Eden’s current pricing page shows a first-month promotional rate as low as $129 for compounded semaglutide; ongoing pricing varies by plan length.

Eden also carries FDA-approved brand-name medications (Ozempic, Wegovy, Zepbound, Mounjaro) for patients who prefer or require them — making it one of the few platforms where you can start compounded and switch to brand-name later without changing providers.

The honest trade-off

Eden’s first-month promo rate is not the ongoing price. Before you enroll, confirm your specific ongoing monthly rate at checkout for your chosen plan length. Eden’s cancellation terms require processing before the next billing date; orders already processed are non-refundable.

Trustpilot: 4.4★ across 3,407+ reviews

SHED (ShedRx) — most format options

SHED offers compounded semaglutide and tirzepatide in more formats than most competitors: weekly injections, daily sublingual drops, and daily dissolvable lozenges — plus FDA-approved Wegovy and Zepbound. Compounded semaglutide starts at $199/month; maintenance dose pricing is $249/month. For brand-name pills (Foundayo, Wegovy pill), SHED charges a $125/month membership with medication priced separately starting at $149/month.

SHED backs its compounded program with a 10% weight-loss guarantee (terms apply — requires weekly weigh-ins, monthly check-ins, and 9 months on the program). There’s a 2-month minimum commitment and cancellation requires 72 hours’ notice before the next billing cycle.

The honest trade-off

SHED does not offer same-price-at-every-dose on compounded semaglutide. If you start at $199 and your provider raises the dose, expect the jump to $249. If you want a needle-free option, the lozenges start at $199 — but oral compounded GLP-1 formulations have not been through the same clinical trial process as FDA-approved versions.

Trustpilot: 4.6★ across 867+ reviews

SkinnyRx — 4.8★ (4,147+ reviews)

Advertises compounded semaglutide injectable “as low as $199/mo*” and carries the strongest Trustpilot profile in the compounded space. Three formats available (injectable, sublingual drops, tablets). However, we could not confirm from the public pricing page alone whether $199 is month-to-month or per-plan. Confirm plan terms at checkout before enrolling.

TrimRx — 3.5★ (1,473 reviews)

Advertises “$199/month with everything included” on one page; another shows tiered pricing: $199 monthly / $142 on 3-month / $124 on 6-month / $99 on annual. Trustpilot reviews mention billing and contact friction. Verify commitment structure and cancellation terms at checkout.

Damaging admission: None of these compounded providers give you the regulatory certainty of an FDA-approved product. If that matters more to you than saving $50/month, the Foundayo and Wegovy pill paths are what you want — and that’s a perfectly reasonable choice. But if you’ve decided compounded is acceptable and your priority is starting at $199 or less with maximum format flexibility, Eden’s same-price-at-every-dose policy and SHED’s format variety are the two strongest starting points we’ve verified.

If you’ll prepay 3–12 months to get the lowest possible rate

TrimRx’s own pricing page shows rates as low as $99/month on an annual plan and $124/month on a 6-month plan — though we could not independently confirm these rates in a live checkout flow. If accurate, those would be among the lowest per-month costs for compounded semaglutide, but they require significant upfront cash.

Who this fits:

Buyers with cash on hand who are confident they’ll stay on the medication for 6–12 months and want the absolute lowest per-month rate.

Who this doesn’t fit:

First-time GLP-1 users who don’t know how they’ll tolerate side effects. Committing $1,000+ before your first injection is a big ask.

If you’re needle-averse and want an under-$200 oral option

Go with Foundayo or the Wegovy pill — both are FDA-approved daily pills, both start at $149/month. Foundayo can be taken any time of day with or without food; the Wegovy pill must be taken on an empty stomach with minimal water.

Check Foundayo on LillyDirect

The 3 Pricing Traps That Push “$199 GLP-1” Over $200

Quick answer: Three patterns push advertised under-$200 GLP-1 pricing above $200 in practice: first-month-only promo pricing that jumps 50–75% on refill, dose escalation that adds $50–$200/month as the prescribed dose increases, and separate membership or visit fees layered on top of the medication price. All three are legal and transparent in the fine print — but they mean the advertised number is not the number you’ll pay on an ongoing basis.

1Trap 1 — First-month-only pricing

Provider	Month 1	Month 2+	Jump
MEDVi compounded semaglutide	$179	$299	+$120
Ro Wegovy pen (0.25/0.5 mg, through June 30, 2026)	$199 (first 2 fills)	$349	+$150
Walgreens + Wegovy pill	~$198 ($49 visit + $149 med)	$299+ at higher doses	+$101+

These are legitimate promotional offers, not scams. But if your budget is strictly under $200 every month, you cannot plan on month-one pricing as your ongoing cost.

2Trap 2 — Dose escalation

Most programs price by milligrams dispensed. A 0.25 mg starter dose is the cheapest. A 2.4 mg maintenance dose costs more. The notable structures:

Eden offers “same price at every dose” on compounded semaglutide — your price doesn’t rise when your doctor adjusts the dose upward. That’s uncommon.
SHED starts compounded semaglutide at $199/month, maintenance dose rises to $249/month.
Foundayo dose ladder (LillyDirect): $149 at 0.8 mg → $199 at 2.5 mg → $299 at 5.5 mg+.
Wegovy pill dose ladder (NovoCare): $149 for 1.5 mg and 4 mg → $299 for 9 mg and 25 mg.

Plan for the maintenance dose, not the starter dose. The price you see in the ad is almost always the starter-dose price.

3Trap 3 — Membership and visit fees on top of medication

This one kills more budgets than the other two combined because it’s a separate recurring line item that doesn’t appear in the medication price.

Ro Body: $39 first month, then as low as $74/month on annual prepay or $149/month monthly. Medication is separate. Cheapest ongoing total: $149 med + $74 membership = $223/month.
GoodRx: Displays $39/month subscription on current live pages (November 2025 press release indicated price rising to $119 — [NEEDS VERIFICATION]). Medication separate.
Walgreens Weight Management: $49 per video or chat visit. Medication separate. Available in listed states only.
SHED brand-name path: $125/month membership on top of medication cost.

True monthly cost = medication + every recurring fee. If a provider doesn’t show you that single number on one line, add it up yourself before clicking “subscribe.”

Promo Deadlines That Change the Math

Mark these on your calendar if you’re deciding:

Wegovy pen intro pricing ($199/fill for 0.25/0.5 mg): ends June 30, 2026
Wegovy pill 4 mg at $149: available through August 31, 2026, then moves to $199
Foundayo pricing: self-pay prices are direct from Eli Lilly — no visible expiration published as of April 2026

Before You Choose a Compounded Option, Read This

Quick answer: Most telehealth GLP-1 programs advertising under $200 use compounded medications, which are a materially different category from FDA-approved products. The FDA states that compounded drugs are not FDA-approved, have not been evaluated for safety, effectiveness, or quality, and should be used only when a prescriber determines that a patient’s medical needs cannot be met by an FDA-approved drug. In February and March 2026, the FDA issued warning letters to more than 30 telehealth companies for marketing claims about compounded GLP-1 products.

We keep compounded and FDA-approved options separate on this page because they’re separate things, and blurring them would mislead you.

What “compounded” means: A compounding pharmacy (licensed under Section 503A or 503B of the Federal Food, Drug, and Cosmetic Act) prepares a medication based on a specific prescription from a licensed clinician. 503A pharmacies are state-licensed and compound patient-specific prescriptions. 503B outsourcing facilities are FDA-registered and follow cGMP standards. Compounded products are not FDA-approved as finished drugs and have not gone through the FDA’s approval process for safety, effectiveness, or quality.

Regulatory status, April 2026: The FDA removed semaglutide from its drug shortage list on February 21, 2025 and tirzepatide in late 2024. With shortages resolved, the legal basis for compounding narrows. The FDA’s April 1, 2026 guidance reminds compounders that specific conditions must be met for compounded drugs to qualify for statutory exemptions. Litigation between compounding industry groups and the FDA continues.

FDA enforcement actions in 2026

On February 6, 2026, the FDA stated it intends to take enforcement action against companies marketing non-FDA-approved compounded GLP-1 products using language that implies FDA approval. On March 3, 2026, the FDA issued warning letters to more than 30 telehealth companies — including MEDVi (February 2026) — for false or misleading marketing of compounded GLP-1 products.

What to verify before paying any compounded provider:

Does the provider disclose its partner compounding pharmacy and its 503A or 503B status?
Is the prescribing clinician licensed in your state?
What’s the exact refill price — not just the first-month price?
What are the cancellation terms and the auto-renewal window?
Has the provider received an FDA warning letter in the past 12 months?

If the compounded regulatory picture makes you uncomfortable: That’s a completely valid reaction. The FDA-approved paths (Foundayo at $149, Wegovy pill at $149) are available right now at comparable starter-dose pricing.

Check Foundayo on LillyDirect See our full FDA-approved comparison

Which Under-$200 Options Have No Separate Membership Fee?

Quick answer: Among the verified routes on this page, LillyDirect and NovoCare manufacturer self-pay pricing includes no separate monthly membership — you pay for the medication and that’s it. Walgreens uses per-visit pricing ($49/visit) instead of a recurring subscription. Eden, SkinnyRx, TrimRx, and SHED position their compounded programs as all-in bundled pricing. Ro and GoodRx add explicit separate monthly membership fees, which is the primary reason they don’t qualify as clean under-$200 paths.

Fee structure	Providers
No separate membership — pay medication price only	LillyDirect (Foundayo), NovoCare (Wegovy pill direct)
Per-visit fee instead of subscription	Walgreens Weight Management ($49/visit)
Bundled/all-in pricing (med + provider + shipping)	Eden, SkinnyRx, TrimRx, SHED (compounded programs)
Separate monthly membership on top of medication	Ro ($39 first month, then $74–$149/mo), GoodRx ($39–$119/mo [NEEDS VERIFICATION]), SHED brand-name path ($125/mo membership)

Insurance Denied Your GLP-1 — What’s the Cheapest Realistic Next Move?

Quick answer: Insurance denial is one of the most common triggers for this search. You have three paths: try the FDA-approved cash-pay route starting at $149/month (Foundayo or Wegovy pill), consider a compounded cash-pay route starting at $199/month (Eden, SHED, or others), or appeal the denial and stay on the insurance track.

If you want to start now and you’re open to cash-pay: The Foundayo and Wegovy pill starter-dose pricing ($149/month) is genuinely accessible without insurance. No prior authorization, no formulary games, no appeals process.
If you’re open to compounded: Eden’s and SHED’s compounded programs start at $199/month with medication, provider access, and shipping included.
If you’d rather fight for coverage first: Some insurers approve GLP-1s on appeal, especially with documentation of prior weight-loss attempts and qualifying comorbidities. See our guide to getting GLP-1 approved by insurance.

You don’t have to choose one path forever. Many people start with a cash-pay option to begin treatment immediately, then transition to insurance-covered brand-name medication once coverage is approved. Eden is particularly well-positioned for this because it offers both compounded and FDA-approved medications on one platform.

What Happens if Compounded GLP-1 Access Narrows Further?

Quick answer: FDA enforcement on compounded GLP-1 products has tightened since the semaglutide shortage ended in February 2025. If compounded access narrows or a specific provider shuts down its compounded program, cash-pay buyers would need to transition to FDA-approved alternatives: Foundayo ($149/month starter dose), Wegovy pill ($149/month starter dose), or brand-name injections like Wegovy ($349/month after intro on Ro) and Zepbound vials ($299–$449/month through LillyDirect).

Our recommendation: Regardless of which provider you start with, get familiar with at least one FDA-approved fallback. Eden offers both compounded and FDA-approved paths under one login, which simplifies a future transition. LillyDirect and NovoCare manufacturer-direct pricing is always available as a standalone backup.

What Patients Actually Say About the Under-$200 Providers

Quick answer: Public reviews from Trustpilot show high marks for customer service at SkinnyRx (4.8★ across 4,147+ reviews), a strong overall experience at SHED (4.6★ across 867+ reviews), and solid satisfaction at Eden (4.4★ across 3,407+ reviews). Reviews reflect service, billing, and support experience — not medical results, which vary individually.

SkinnyRx★★★★★4.8 · 4,147+ reviews (Trustpilot)

Reviewers consistently mention fast approvals, responsive staff, and clear communication. SkinnyRx responds publicly to 98% of negative Trustpilot reviews, typically within a week — a meaningful trust signal for a telehealth company.

Eden★★★★4.4 · 3,407+ reviews (Trustpilot)

Reviewers cite flat-rate pricing, variety of medication formats (compounded injectable, oral drops, gummies, plus brand-name access), and community support features in Eden’s app. Named medical advisory board members are listed on the site.

SHED★★★★★4.6 · 867+ reviews (Trustpilot)

Strong overall satisfaction. Format variety (injections, lozenges, drops) and the 10% weight-loss guarantee stand out in positive reviews. The 2-month minimum and dose escalation price jump are the most common complaints.

TrimRx★★★3.5 · 1,473 reviews (Trustpilot)

The mixed profile is worth acknowledging. Positive reviews cite effective treatment and competitive pricing. Negative reviews cite billing friction and difficulty reaching support. Verify the cancellation policy in writing before enrolling.

Reviews are useful for evaluating operational quality: shipping speed, support responsiveness, billing clarity. They are not proof that a medication will produce specific results for you. Testimonials are not paid.

How We Verified Every Price on This Page

Quick answer: We checked each provider’s live pricing page, terms of service, cancellation policy, and — where accessible — checkout flow between April 10 and April 15, 2026. Claims we could not confirm from a primary source are marked [NEEDS VERIFICATION]. We re-verify monthly.

Commercial facts verified:

Advertised price
Refill price
Dose-tier pricing
Membership fees
Visit fees
Cancellation window
Auto-renewal terms
State availability where stated
Trustpilot review count and rating

Medical/regulatory facts verified:

FDA approval status per approved drug labels
FDA drug shortage list status
FDA warning letters (sourced from FDA.gov)
Medicare GLP-1 Bridge program details (sourced from CMS)

What we flagged [NEEDS VERIFICATION]:

SkinnyRx exact ongoing month-to-month pricing without plan commitment
TrimRx commitment structure vs. advertised $199 rate
GoodRx current live standard membership price
Eden's exact ongoing rate by plan length

Last verified: April 15, 2026 · Next scheduled verification: May 15, 2026 · Methodology: official pricing page → terms of service → cancellation page → Trustpilot profile → FDA.gov for regulatory claims → publish with timestamps.

Frequently Asked Questions

Yes — but the list is narrower than the ads suggest. The FDA-approved Wegovy pill and Foundayo both start at $149/month at lower doses through manufacturer-direct pricing (NovoCare and LillyDirect). Compounded semaglutide from telehealth providers like Eden and SHED starts at $199/month. Most other advertised under-$200 prices are first-month promos that rise to $229–$349 on refill.

Foundayo on LillyDirect and the Wegovy pill on NovoCare both start at $149/month at their lower doses. These are the two lowest-cost FDA-approved GLP-1 paths for weight management verified in April 2026.

Usually, yes. Foundayo rises from $149/month at 0.8 mg to $299/month at 5.5 mg+. The Wegovy pill rises from $149/month to $299/month at 9 mg+. Most compounded providers also charge more at higher doses. The notable exception is Eden, which states a same-price-at-every-dose policy on compounded semaglutide.

LillyDirect (Foundayo) and NovoCare (Wegovy pill) charge only for the medication with no separate membership. Walgreens uses per-visit pricing ($49/visit). Eden, SkinnyRx, TrimRx, and SHED bundle provider access into the medication price. Ro and GoodRx charge separate monthly memberships on top of medication cost.

No. Compounded GLP-1 medications are not FDA-approved as finished products. The FDA has not reviewed them for safety, effectiveness, or quality. They are legally available when prescribed by a licensed clinician and prepared by a licensed compounding pharmacy, but they are not equivalent to FDA-approved drugs.

Not in the mainstream routes verified in April 2026. Compounded tirzepatide typically costs $249–$349/month. FDA-approved Zepbound in vial form costs $299–$449/month through LillyDirect. If you need tirzepatide specifically, budget above $200.

Five things: (1) What is the refill price — not just the first-month price? (2) Does the price increase at higher doses? (3) Is there a membership, visit, or shipping fee on top of medication? (4) What is the cancellation window — how far in advance must you cancel to avoid the next charge? (5) If compounded: who is the compounding pharmacy, and what is its licensing status?

In clinical trials, the 25 mg Wegovy tablet produced approximately 13.6% average body weight reduction at Week 64. Comparable injectable Wegovy trials showed approximately 15% average body weight reduction. The pill is slightly less efficacious on average, but for many people the difference is small and the convenience of a daily pill removes a meaningful barrier.

Yes. Most featured providers accept HSA (Health Savings Account) and FSA (Flexible Spending Account) cards for both compounded and FDA-approved GLP-1 medications.

Still not sure which path is right for you?

We built a free 60-second matching quiz that asks about your budget, preferred format, state, and whether you want FDA-approved or compounded — and matches you to the best-fit option.

Take the free GLP-1 path quiz

Or, if you already know what you want:

FDA-approved oral pill, no injection: Check Foundayo on LillyDirect
Compounded, same price at every dose, brand-name backup:
Compounded, multiple med formats, weight-loss guarantee:
Not sure / want more options: Compare all GLP-1 programs

Affiliate Disclosure

Weight Loss Provider Guide is an independent comparison resource for GLP-1 telehealth providers. Some links in this article are affiliate links. If you sign up with a provider through our link, we may earn a commission at no additional cost to you. Affiliate relationships do not influence which providers we feature, how we verify pricing, or our tier classifications. Our editorial process is explained in the methodology section above.

Medical Disclaimer

This article is for informational purposes only and is not medical advice. GLP-1 medications require a prescription from a licensed healthcare provider. Do not start or stop any medication based on this article. Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality. Individual results vary. Always consult a qualified healthcare professional before starting any treatment.